iAssay Receives Notice of Allowance for New U.S. Patent for Universal Portable Assay Device
SAN DIEGO, CA – January 4, 2022 – iAssay® Inc., a privately held developer of the world’s first open platform, point of care (POC) reader for remote medical diagnostics, announced today that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. Patent Application 17/001,069. The allowed patent includes 19 claims, key claims relating to the processing of multiple unique test devices simultaneously in a common drawer, mechanisms for decoding identifiers, and lateral flow test results based on line intensity/color. The patent is expected to issue in mid-2022.
“There is a significant unmet need in healthcare today for a single device at the point of care that has the capability to operate multiple different assay modules,” said Lonnie Adelman, founder, and CEO of iAssay. “The development of the iAssay universal handheld diagnostic system has the potential to significantly reduce healthcare costs, simplify care providers’ workflow and ultimately improve patient care.”
The company’s growing patent portfolio covers the functionality that enables care providers to perform multiple type assay tests simultaneously by adapting POC test cartridges of various formats and technologies to one device. Claims also cover device wireless communications and plug-in modules that expand the hardware and processing capabilities of the handheld and benchtop models. Further, claims cover the capability to guide the care provider during sample collection and processing, including the ability to decide whether to continue a test or perform certain steps of a test based on interim results as the test progresses.
“This notice of allowance strengthens the value of our pipeline with near-term intellectual property protection and highlights iAssay’s innovation in a proprietary, multi-use diagnostics for point of care testing,” stated Adelman. “We are excited to be one step closer to bringing this groundbreaking innovation to caregivers.”
The iAssay® System is the world’s first open platform for wirelessly-connected point of care diagnostics. The functionality of a closet full of single function readers is replaced by one handheld device and adaptor plug-ins, to adapt nearly any point of care test cartridge to the iAssay System. The HIPAA-compliant device aggregates test/patient/wearable biometric data and pushes all data into the cloud. iAssay eliminates multiple daily trips with blood samples to central labs by testing the patient wherever they are. Testing at a pharmacy clinic or at the patients’ bedside in a few minutes eliminates test result delays (and delayed diagnosis), eliminates sample handling and transportation costs, improves patient outcomes, and saves the healthcare system money.